STFC's Daresbury Lab to test next generation of cancer treatment
Technology at the heart of the Large Hadron Collider is being developed in the North West to treat cancer. A new proton therapy assembly and test facility will be built at the STFC Daresbury Laboratory in a collaboration with British firm Advanced Oncotherapy.
The treatment produces fewer side effects than conventional radiotherapy. It uses beams of protons – part of the atom – to precisely target cancerous tumours while limiting damage to surrounding organs or tissue. Offering higher disease-free survival rates, proton therapy is most often used to treat brain tumours in young children whose organs and tissues are still developing, or cancers adjacent to critical part of the body (liver, lung, head and neck, prostate, breast).
The company said the Lab, at the Sci-Tech Daresbury Campus in the Liverpool City Region, will become the mass-assembly and testing location for the next generation of proton particle accelerator. It said its ‘LIGHT’ system is expected to be the first commercially available linear proton accelerator and would be a milestone advancement in cancer therapy.